Abstract
Since the first New Delhi metallo-beta-lactamase (NDM) report in 2009, NDM has spread globally causing various types of infections. NDM-positive organisms produce in vitro resistance phenotypes to carbapenems and many other antimicrobials. It is thus surprising that the literature examining clinical experiences with NDM does not report corresponding poor clinical outcomes. There are many instances where good clinical outcomes are described, despite a mismatch between administered antimicrobials and resistant in vitro susceptibilities. Available in vitro data for either monotherapy or combination therapy does not provide an explanation for these observations. However, animal studies do begin to shed more light on this phenomenon. They imply that the in vivo expression of NDM may not confer clinical resistance to all cephalosporin and carbapenem antibiotics as predicted by in vitro testing but other resistance mechanisms need to be present to generate a resistant phenotype. As such, previously abandoned therapies, particularly carbapenems and beta-lactamase inhibitor combinations, may retain utility against infections caused by NDM producers.
Citations
Aug 24, 2016·Frontiers in Microbiology·Somdatta ChatterjeeSulagna Basu
Dec 13, 2017·Antimicrobial Agents and Chemotherapy·Alex J HollowayTonyia Eaves-Pyles
Aug 1, 2018·International Journal of Molecular Sciences·Warawan EiamphungpornChanin Nantasenamat
Jul 15, 2016·Clinical Microbiology Reviews·Mordechai GrupperDavid P Nicolau
Jan 16, 2019·Antimicrobial Agents and Chemotherapy·W J WeissE J Growcott
Sep 10, 2019·Protein Science : a Publication of the Protein Society·Simon Booth, Richard J Lewis
Jan 23, 2020·Microorganisms·Yogandree RamsamySabiha Y Essack
Jan 14, 2020·The Journal of Antimicrobial Chemotherapy·Tomefa E AsempaDavid P Nicolau
May 20, 2020·Antimicrobial Agents and Chemotherapy·Ariane RoujanskyBruno Fantin
Jun 28, 2020·The Journal of Antimicrobial Chemotherapy·Misha I KaziJoseph M Boll
Sep 17, 2017·Infection·Vindana ChibabhaiWarren Lowman
Aug 18, 2020·Infection and Drug Resistance·John F Kokai-KunSheila Connelly
Apr 11, 2020·Infection and Drug Resistance·Lingtong TangYingshun Zhou
Sep 29, 2020·Infection and Drug Resistance·Hangbin HuTingting Qu
May 29, 2018·Scientific Reports·Frank FleurbaaijPaul J Hensbergen
Jun 16, 2021·Chemical Reviews·Guillermo BahrAlejandro J Vila
Aug 26, 2021·Journal of Medical Microbiology·Kohei UechiJiro Fujita